Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lewis John Alfred"'
Autor:
Hanneke Schuitemaker, Lewis John Alfred, Barbara Petronella Sanders, F. Uytdehaag, Jaap Goudsmit, Martin H. Koldijk, Diana Edo-Matas, Wilfried A.M. Bakker, Jerome Custers, Vincent Klaren, Alfred Luitjens, Marije Turk
Publikováno v:
Vaccine, 31(5), 850-856. Elsevier BV
There are two highly efficacious poliovirus vaccines: Sabin's live-attenuated oral polio vaccine (OPV) and Salk's inactivated polio vaccine (IPV). OPV can be made at low costs per dose and is easily administrated. However, the major drawback is the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb218d13cf966af08f5e085d5a17b66d
https://doi.org/10.1016/j.vaccine.2012.10.070
https://doi.org/10.1016/j.vaccine.2012.10.070
Autor:
Lewis John Alfred, Jaap Goudsmit, Giuseppe Marzio, C. Ophorst, Martin H. Koldijk, Gerrit Jan Weverling, F. Uytdehaag, Linda Gijsbers, Johannes A. Bogaards, Stefan Kostense, M Ter Haak, Just P. J. Brakenhoff, M de Vocht, J.Y. Guichoux
Publikováno v:
Koldijk, M H, Bogaards, J A, Kostense, S, de Vocht, M, Gijsbers, L, ter Haak, M, Ophorst, C, Brakenhoff, J P J, Weverling, G J, Guichoux, J Y, UytdeHaag, F, Lewis, J, Goudsmit, J & Marzio, G 2007, ' A sensitive cell-based assay for the detection of residual infectious West Nile virus ', Vaccine, vol. 25, no. 39-40, pp. 6872-6881 . https://doi.org/10.1016/j.vaccine.2007.07.011
Vaccine, 25(39-40), 6872-6881. Elsevier BV
Vaccine, 25(39-40), 6872-6881. Elsevier BV
Ensuring complete viral inactivation is critical for the safety of vaccines based on an inactivated virus. Detection of residual infectious virus is dependent on sensitivity of the assay, sample volume analyzed and the absence of interference with vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::318dd496eff06edd49f673314200b7b3
https://doi.org/10.1016/j.vaccine.2007.07.011
https://doi.org/10.1016/j.vaccine.2007.07.011
Autor:
Jerome Custers, Jeronimo Cello, Lewis John Alfred, Isabel de los Rios Oakes, Ying Liu, Vladimir van Hoek, Eckard Wimmer, Diana Edo-Matas, Barbara Petronella Sanders, Hanneke Schuitemaker, Alies Brandjes
Publikováno v:
The Journal of general virology. 96(9)
Brunenders, a type I poliovirus (PV) strain, was developed in 1952 by J. F. Enders and colleagues through serial in vitro passaging of the parental Brunhilde strain, and was reported to display partial neuroattenuation in monkeys. This phenotype of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ecf00fcfdec46b7991bda3e8288dcf2
https://pubmed.ncbi.nlm.nih.gov/26018960
https://pubmed.ncbi.nlm.nih.gov/26018960
Autor:
Lewis John Alfred, Javier Martin, Isabel de los Rios Oakes, Vladimir van Hoek, Viki Bockstal, Laura Crawt, Taco G. Uil, Gillian Cooper, Yutong Song, Eckard Wimmer, Diana Edo-Matas, Roland Zahn, Barbara Petronella Sanders, Hanneke Schuitemaker, Jerome Custers, Jeronimo Cello, Tobias Kamphuis
Publikováno v:
PLoS Pathogens, Vol 12, Iss 3, p e1005483 (2016)
PLoS Pathogens
PLoS Pathogens
The poliovirus vaccine field is moving towards novel vaccination strategies. Withdrawal of the Oral Poliovirus Vaccine and implementation of the conventional Inactivated Poliovirus Vaccine (cIPV) is imminent. Moreover, replacement of the virulent pol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c71f9f52109ac468adeca8ea53a0114
https://doi.org/10.1371/journal.ppat.1005483
https://doi.org/10.1371/journal.ppat.1005483
Publikováno v:
Biopharmaceutical Production Technology, Volume 1 & Volume 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe8dcfb3a03c4fa4d84ca3bd279f89b8
https://doi.org/10.1002/9783527653096.ch26
https://doi.org/10.1002/9783527653096.ch26
Publikováno v:
Encyclopedia of Industrial Biotechnology
Human cell lines are becoming increasingly attractive for the expression of proteins in both research and commercial production of human therapeutics. Most of the recent interest derives not only from the recent achievements in record levels of prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::029ba236c6bef8c6ff58af02229c04e8
https://doi.org/10.1002/9780470054581.eib336
https://doi.org/10.1002/9780470054581.eib336
Autor:
A. De Groot, Lewis John Alfred, Stephany C. Koelewijn, Gerrit Jan Weverling, E. Kerkvliet, Menzo J. E. Havenga, Johannes A. Bogaards, Ronald Vogels, Jaap Goudsmit, Maria Grazia Pau, J.Y. Guichoux, Linda Gijsbers, Jerome Custers, Giuseppe Marzio
Publikováno v:
Vaccine, 25(12), 2228-2237. Elsevier BV
Marzio, G, Kerkvliet, E, Bogaards, J A, Koelewijn, S, De Groot, A, Gijsbers, L, Weverling, G J, Vogels, R, Havenga, M, Custers, J, Pau, M G, Guichoux, J Y, Lewis, J & Goudsmit, J 2007, ' A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells ', Vaccine, vol. 25, no. 12, pp. 2228-2237 . https://doi.org/10.1016/j.vaccine.2006.12.011
Marzio, G, Kerkvliet, E, Bogaards, J A, Koelewijn, S, De Groot, A, Gijsbers, L, Weverling, G J, Vogels, R, Havenga, M, Custers, J, Pau, M G, Guichoux, J Y, Lewis, J & Goudsmit, J 2007, ' A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells ', Vaccine, vol. 25, no. 12, pp. 2228-2237 . https://doi.org/10.1016/j.vaccine.2006.12.011
The presence of replication-competent adenovirus (RCA) is a safety concern for biologics based on recombinant adenoviruses and RCA testing is therefore mandatory for release of clinical material. RCA, which arises from homologous recombination betwee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::129f681e3f2f4b70eb53167af240f07a
https://pure.amc.nl/en/publications/a-replicationcompetent-adenovirus-assay-for-e1deleted-ad35-vectors-produced-in-perc6-cells(27e0a348-55be-4cdf-9cdd-b110c60dc912).html
https://pure.amc.nl/en/publications/a-replicationcompetent-adenovirus-assay-for-e1deleted-ad35-vectors-produced-in-perc6-cells(27e0a348-55be-4cdf-9cdd-b110c60dc912).html